JHSM

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

EndNote Style
Index
Original Article
Assessment of vitamin D deficiency and hyperparathyroidism in metabolically healthy and unhealthy obese patients
Aims: This study aimed to compare the levels of vitamin D in metabolically healthy (MHO) and metabolically unhealthy obese (MUO) individuals and determine if there are differences between these two groups concerning vitamin D deficiency and hyperparathyroidism.
Methods: A total of 263 obese female patients were included in the study and divided into two groups based on metabolic syndrome diagnostic criteria. Biochemical and anthropometric data obtained after a 12-hour fasting period were analyzed.
Results: Among the patients, the average 25-OH vitamin D level was 10.9±6.5 ng/ml. A total of 242 patients (92%) had vitamin D deficiency, and 132 patients (50.2%) were diagnosed with hyperparathyroidism. Significant differences were found in vitamin D (p=0.003) and uric acid (p<0.001) levels between the MHO and MUO groups. Additionally, the groups with vitamin D deficiency showed significantly different glucose (p=0.026) and homeostatic model assessment for insulin resistance (p=0.042) values. Patients with hyperparathyroidism had higher waist circumference (p<0.001), waist-to-hip ratio (p=0.018), BMI (p=0.006), and systolic (p=0.001) and diastolic (p<0.001) blood pressure values compared to those with normal parathyroid hormone levels.
Conclusion: The study emphasizes the importance of monitoring vitamin D deficiency and hyperparathyroidism in obese patients, as these conditions are more prevalent in this population and might be associated with metabolic syndrome parameters, increasing cardiometabolic risk.


1. The GBD 2015 Obesity Collaborators. Health effects ofoverweight and obesity in 195 countries over 25 years. N Engl JMed . 2017;377(1):13-27.
2. Stival C, Lugo A, Odone A, et al. Prevalence and correlates ofoverweight and obesity in 12 European Countries in 2017-2018.Obes Facts. 2022;15(5):655-665.
3. Magkos F. Metabolically healthy obesity: what-s in a name? Am JClin Nutr. 2019;110(3):533-539. doi:https://doi.org/10.1093/ajcn/nqz133
4. Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity:facts and fantasies. J Clin Invest. 2019;129(10):3978-3989.
5. Szymczak-Pajor I, Sliwinska A. Analysis of associationbetween vitamin D deficiency and insulin resistance. Nutrients.2019;11(4):794.
6. Doğan M, Doğan AG, Hastanesi A, et al. Vitamin D yetersizliğive eksikliğine g&uuml;ncel yaklaşım. J Health Sci Med. 2019;2(2):58-61.doi:10.32322/JHSM.496326
7. Vranic L, Mikola&scaron;evic I, Milic S. Vitamin D deficiency: consequenceor cause of obesity? Medicina (B Aires). 2019;55(9):541.
8. Karampela I, Sakelliou A, Vallianou N, Christodoulatos GS,Magkos F, Dalamaga M. Vitamin D and obesity: currentevidence and controversies. Curr Obes Rep. 2021;10(2):162-180.doi:10.1007/S13679-021-00433-1/FIGURES/1
9. Trimarco V, Manzi MV, Mancusi C, et al. Insulin resistanceand vitamin D deficiency: a link beyond the appearances. FrontCardiovasc Med. 2022;9:859793.
10. Şabanoğlu C, İnan&ccedil; İH. The relationship between vitamin Ddeficiency and hypertensive organ damage. J Health Sci Med.2022;5(6):1704-1712. doi:10.32322/jhsm.1173794
11. Ford ES, Zhao G, Li C, Pearson WS. Serum concentrations ofvitamin D and parathyroid hormone and prevalent metabolicsyndrome among adults in the United States. J Diabetes.2009;1(4):296-303. doi:10.1111/J.1753-0407.2009.00046.X
12. Grethen E, McClintock R, Gupta CE, et al. Vitamin D andhyperparathyroidism in obesity. J Clin Endocrinol Metab. 2011;96(5):1320-1326.
13. Andersen T, McNair P, Hyldstrup L, et al. Secondaryhyperparathyroidism of morbid obesity regresses during weightreduction. Metabolism. 1988;37(5):425-428.
14. Grundy SM, Cleeman JI, Merz CNB, et al. Implications of recentclinical trials for the national cholesterol education program adulttreatment panel III guidelines. Circulation. 2004;110(2):227-239.
15. T&uuml;rkiye Endokrinoloji ve Metabolizma Derneği Obezite LipidMetabolizmasi Hipertansiyon &Ccedil;alişma Grubu. TEMD ObeziteTanı ve Tedavi Kılavuzu 2019. TEMD; 2019.
16. Cigerli O, Parildar H, Unal AD, Tarcin O, Erdal R, Guvener DemiragN. Vitamin D deficiency is a problem for adult out-patients? Auniversity hospital sample in İstanbul, Turkey. Public Health Nutr.2013;16(7):1306-1313. doi:10.1017/S1368980012003588
17. Cinar N, Harmanci A, Yildiz BO, Bayraktar M. Vitamin Dstatus and seasonal changes in plasma concentrations of25-hydroxyvitamin D in office workers in Ankara, Turkey. Eur JIntern Med. 2014;25(2):197-201. doi:10.1016/J.EJIM.2013.11.004
18. G&ouml;ktaş O, Ersoy C, Ercan I, Can FE. Vitamin D status in the adultpopulation of Bursa-Turkey. Eur J Gen Pract. 2020;26(1):156-162.doi:10.1080/13814788.2020.1846712
19. Walsh JS, Bowles S, Evans AL. Vitamin D in obesity. Curr OpinEndocrinol Diabetes Obes. 2017;24(6):389-394. doi:10.1097/MED.0000000000000371
20. Pourshahidi LK. Vitamin D and obesity: current perspectives andfuture directions. Proc Nutr Soc. 2015;74(2):115-124. doi:10.1017/S0029665114001578
21. Osmancevic A, Gillstedt M, Landin-Wilhelmsen K, et al. Sizeof the exposed body surface area, skin erythema and body massindex predict skin production of vitamin D. J Photochem PhotobiolB . 2015;149:224-229.
22. Bell N, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S.Evidence for alteration of the vitamin D-endocrine system inobese subjects. Am Soc Clin Investig. 1985:370-373.
23. Schmitt EB, Nahas-Neto J, Bueloni-Dias F, Poloni PF, Orsatti CL,Petri Nahas EA. Vitamin D deficiency is associated with metabolicsyndrome in postmenopausal women. Maturitas. 2018;107:97-102. doi:10.1016/j.maturitas.2017.10.011
24. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA,V&aacute;zquez C, Escobar-Morreale HF. Vitamin D deficiency isassociated with the metabolic syndrome in morbid obesity. ClinNutr. 2007;26(5):573-580. doi:10.1016/J.CLNU.2007.05.009
25. Lee SJ, Lee EY, Lee JH, et al. Associations of serum25-hydroxyvitamin D with metabolic syndrome and itscomponents in elderly men and women: The Korean Urban RuralElderly cohort study. BMC Geriatr. 2019;19(1):1-8. doi:10.1186/S12877-019-1118-Y/TABLES/5
26. Zhu W, Heil DP. Associations of vitamin D status with markersof metabolic health: a community-based study in Shanghai,China. Diabetes Metab Syndr. 2018;12(5):727-732. doi:10.1016/J.DSX.2018.04.010
27. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormonelevel is associated with body mass index. The 5th Tromso study.Eur J Endocrinol. 2004;151(2):167-172. doi:10.1530/eje.0.1510167
28. Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, ReidIR. Fat mass is an important predictor of parathyroid hormonelevels in postmenopausal women. Bone. 2006;38(3):317-321.doi:10.1016/j.bone.2005.08.018
29. Pitroda AP, Harris SS, Dawson-Hughes B. The association ofadiposity with parathyroid hormone in healthy older adults.Endocrine. 2009;36(2):218-223. doi:10.1007/S12020-009-9231-X/TABLES/4
30. Stein EM, Strain G, Sinha N, et al. Vitamin D insufficiency priorto bariatric surgery: risk factors and a pilot treatment study.Clin Endocrinol (Oxf). 2009;71(2):176-183. doi:10.1111/J.1365-2265.2008.03470.X
31. Fish E, Beverstein G, Olson D, Reinhardt S, Garren M, Gould J.Vitamin D status of morbidly obese bariatric surgery patients. JSurg Res. 2010;164(2):198-202. doi:10.1016/J.JSS.2010.06.029
32. Salazar DA, Ferreira MJS, Neves JS, et al. Variable Thresholdsof Vitamin D Plasma Levels to Suppress PTH: the Effect ofWeight and Bariatric Surgery. Obes Surg. 2020;30(4):1551-1559.doi:10.1007/S11695-019-04351-Z/TABLES/7
Volume 6, Issue 5, 2023
Page : 968-973
_Footer